Psilocybin and Migraine: First of Its Kind Trial Reports Promising Results (newatlas.com) 61
An anonymous reader quotes a report from New Atlas: A first-of-its-kind exploratory study, led by researchers from Yale School of Medicine, has found a single dose of the psychedelic psilocybin can reduce migraine frequency by 50 percent for a least two weeks. The preliminary trial was small, with follow-up work necessary to validate the results, but the promising findings suggest great potential for psychedelics to treat migraines and cluster headaches.
A new study, published in the journal Neurotherapeutics, is offering the first double-blind, placebo-controlled, cross-over study on the effects of a moderate psilocybin dose on migraine frequency and severity. The research is only preliminary and small but its results are deeply encouraging. Ten migraine sufferers were recruited for the trial. Each subject completed two sessions, one with a placebo and one with a moderate psilocybin dose. Headache diaries were used to track headache frequency and severity in the two weeks leading up to, and following, each experimental session. "Compared to placebo, a single administration of psilocybin reduced migraine frequency by about half over the two weeks measured," explains corresponding author on the new study Emmanuelle Schindler, in an email to New Atlas. "In addition, when migraine attacks did occur in those two weeks, pain intensity and functional impairment during attacks were reduced by approximately 30 percent each."
Perhaps the most intriguing finding from this small study was the lack of any correlation between the subjective strength of the psychedelic experience and the therapeutic effect. Prior trials using psilocybin to treat depression or addiction have suggested the overwhelming magnitude of a psychedelic experience seems to be fundamentally entwined with its therapeutic efficacy. So essentially, the more powerful the experience the better the result. But unexpectedly, this migraine/psilocybin trial did not detect that association. In fact, those subjects reporting the highest scores on a self-reported altered state of consciousness scale showed some of the smaller reductions in migraine burden. What this intriguingly suggests is that, in the case of psilocybin for migraine, it may be possible to separate out the drug's psychotropic effects from its therapeutic effects. This could be achieved either by exploring microdoses and sub-hallucinogenic doses, or even homing in on the mechanism by which the drug is helping prevent migraines and finding a new way to pharmacologically target it.
A new study, published in the journal Neurotherapeutics, is offering the first double-blind, placebo-controlled, cross-over study on the effects of a moderate psilocybin dose on migraine frequency and severity. The research is only preliminary and small but its results are deeply encouraging. Ten migraine sufferers were recruited for the trial. Each subject completed two sessions, one with a placebo and one with a moderate psilocybin dose. Headache diaries were used to track headache frequency and severity in the two weeks leading up to, and following, each experimental session. "Compared to placebo, a single administration of psilocybin reduced migraine frequency by about half over the two weeks measured," explains corresponding author on the new study Emmanuelle Schindler, in an email to New Atlas. "In addition, when migraine attacks did occur in those two weeks, pain intensity and functional impairment during attacks were reduced by approximately 30 percent each."
Perhaps the most intriguing finding from this small study was the lack of any correlation between the subjective strength of the psychedelic experience and the therapeutic effect. Prior trials using psilocybin to treat depression or addiction have suggested the overwhelming magnitude of a psychedelic experience seems to be fundamentally entwined with its therapeutic efficacy. So essentially, the more powerful the experience the better the result. But unexpectedly, this migraine/psilocybin trial did not detect that association. In fact, those subjects reporting the highest scores on a self-reported altered state of consciousness scale showed some of the smaller reductions in migraine burden. What this intriguingly suggests is that, in the case of psilocybin for migraine, it may be possible to separate out the drug's psychotropic effects from its therapeutic effects. This could be achieved either by exploring microdoses and sub-hallucinogenic doses, or even homing in on the mechanism by which the drug is helping prevent migraines and finding a new way to pharmacologically target it.
Re: (Score:2, Insightful)
Be cool, fuckin' narc.
Re: (Score:1)
Re:Slashdot is pushing drugs now? (Score:4, Insightful)
Pushing, definitely.
Popping (or any other method) is free choice in action, on a topic that only really impacts yourself (the excesses of uncontrolled addiction notwithstanding) and the fact that so many of the most dangerous and addictive drugs enjoy widespread acceptance is evidence that most of society agrees, at least for their own drugs of choice (alcohol, tobacco, caffeine, etc)
Pushing is an attempt to pressure people into using drugs they wouldn't have chosen on their own - an intentional attempt to profit from the subversion of other people's free will and good judgement.
Re:Slashdot is pushing drugs now? (Score:4, Funny)
Yes, because all uses of all drugs are exactly the same. Slashdot publishes a report on a possible very useful application, and the best you can come up with is Slashdot is pushing drugs now? And then, in a flash, I realized that I just replied to a troll. Bad me!
Re: (Score:2)
Rite-aid is pushing drugs
Slashdot is just secondhand-reporting on them
How do you keep a psilocybin study double blind? (Score:5, Interesting)
I don't have personal experience with psilocybin, but is the effect variable enough that those taking the placebo wouldn't have a pretty good idea that they just had a placebo?
I'm genuinely curious how such a study would maintain its double-blind nature.
(In true /. form, I barely read the summary, let alone the article...)
Re:How do you keep a psilocybin study double blind (Score:4, Funny)
Who cares? I have a headache now gimme some 'shrooms!
Re:How do you keep a psilocybin study double blind (Score:4, Interesting)
It's possible that the effective dose level is below what would produce psychedelic effects.
Some people who are interested in nootropics use "microdoses" of LSD. The goal is to promote creative or more flexible thinking without any perceptible hallucinations.
It's an intriguing idea, but so far as I know there's no scientific evidence to support or refute it. Most of the information out there is self-reports, which of course are useless. People who are up for this kind of self-experimentation probably aren't the idea subjects, either.
Re: How do you keep a psilocybin study double blin (Score:2)
Is self-reporting useless? (Score:2)
Re: (Score:3)
I read the abstract (the article is paywalled).
Changes in migraine frequency in the 2 weeks after psilocybin were not correlated with the intensity of acute psychotropic effects during drug administration. .... This exploratory study suggests there is an enduring therapeutic effect in migraine headache after a single administration of psilocybin. The separation of acute psychotropic effects and lasting therapeutic effects is an important finding, urging further investigation into the mechanism underlying the clinical effects
That pretty clearly implies that there were psychoactive effects experienced. So, yup, there's little point to doing the experiment double-blind since the patient is clearly unblinded by secondary effects. At least they used a cross-over structure (group A got the drugs for a period, then placebos; group B got placebos first and then the drugs).
Re: How do you keep a psilocybin study double blin (Score:3)
Some people are immune (Score:2)
A friend of mine has taken shrooms with me 3 times, the last double what I did, and he felt absolutely nothing. Once for his brother too. They're Italians, very Roman-looking.
Re: (Score:2)
No one would know they were taking psilocybin directly. They'd just know they were taking a drug, and it could help with migraines, or it may not.
And during drug trails, they don't know what the side effects are, so they ask the participants to report any side effects they feel. So if the dose is high enough to feel the effects, they'd report feeling rather loopy or other side effects common with being on magic mushrooms.
In Canada, there actually are studies going on as well - 3 people have obtained permits
Re: (Score:1)
How long does it last? (Score:2, Flamebait)
Re: (Score:2)
To psylocibin? No, it doesn't, although an experienced user can function better under the same dose than a newbie they're still tripping the same amount.
Re: (Score:2)
Re: (Score:2)
So reading comprehension is not your strong point. Got it. What I said was the exact opposite. I'll rephrase it for you.
The body doesn't "build up tolerance" to psylocibin. An experienced user and a new user will be tripping the same amount, brain scans show that. The experienced user will just be able to function better because they've learned how.
Re: (Score:2)
Re: (Score:2)
You can build up a tolerance to mushrooms after using every day for as few as 3 or 4 days. This means you need to take more and more of the drug to get “high” like you did the first time. If you use mushrooms for several days in a row (continuous use), you can develop a complete tolerance.
Re: (Score:2)
Re: (Score:2)
No idea where you found it, but it's wrong. I lived with a bunch of hippies for a long time. An experienced user can still function pretty well even when the world around him is doing strange things, it's a matter of compensation. Complete tolerance? You must be reading the DEA web site.
Re: (Score:2)
Re: (Score:2)
Re: (Score:2)
Re: (Score:2)
The article did not say it completely blocked migraines for this two week period nor did it follow people for a lifetime.
Good news for migraine sufferers (Score:2)
Re: (Score:2)
> you've got a security clearance or work in other jobs that require drug tests. You get to endure intense pain
The catch-22 is that if they had a psychedelic experience or two, they'd leave those 'blowing-up-poor-people' jobs.
The System is entirely self-reenforcing by doing those random drug tests and would defeat itself by doing otherwise. Wilson was a tyrant, but no dummy. He knew that humans had used mushrooms for the previous couple hundred thousand yearsâ"the literary references stretch all t
Re: Good news for migraine sufferers (Score:1)
Re: (Score:2)
Unless you live in Denver, CO; Oakland, CA; Santa Cruz, CA; or the state of Oregon. The feds don't have a mushroom user task force yet.
the good old days (Score:2)
the good old days, magic mushies were great
never thought about it, but can't remember having headaches associated with tripping on mushies,
matter of fact can't remember much about those years,
oh, except for seeing the halo surrounding Mick and Jane while listening to Genesis
oh, and the magic colours of our skin
oh, and going surfing while tripping
oh wow, flashbacks, cool, groovy and far out
Re: (Score:3)
Re: (Score:2)
Not sure how /. turned my reply into "Mp", I'll try again.
Considering that everything you said runs contrary to everything known about the condition, that's going to be a big [citation needed].
Re: (Score:1)
Re: useless non-cure (Score:1)
Re: (Score:2)
Yes, allergies to food or food additives are common causes. Not just eating. Your link says nothing about weight or obesity. Get a grip.
Too stoned to notice? (Score:2)
Maybe it's because the subjects were too out of it to notice the migraine. Anesthesia probably has the same effect.
Re: (Score:2)
Unless you're a McKenna, nobody gets stoned for two weeks.
Re: Too stoned to notice? (Score:1)
Re: (Score:1)
...the moderate dosages cited would not be sufficient to mask even moderate pain, let alone the debilitating pain associated with Migraines.
That is quite the statement you've got there, as we sit here discussing the very study. I'm quite certain that if the moderate doses cited would have not been sufficient to mask even moderate pain, let alone the debilitating pain associated with Migraines, we would almost assuredly not be sitting here discussing a study on the positive results of using Psilocybin to combat Migraines.
And quite honestly, if too stoned to notice is the argument here, point me in the direction of the perfectly sober pill popp
Re: Too stoned to notice? (Score:3, Informative)
Re: (Score:2)
The effect being reported here is a reduction in Migraine frequency after the Psilocybin has left the body, not an analgesic effect of Psilocybin whilst under its influence. Being someone who takes Triptans for relief from the acute Migraine phase, I can testify that there is no broad analgesic effect (at least from this relative to Psilocybin) - even though the Migraine pain rapidly reduces. The relief is believed to be caused by the vasoconstrictive properties of the medication. Traditional analgesics are quite useless against Migraines. Having been given all sorts of strong opiate and anti-inflammatory analgesics in Emergency Rooms in my early Migraine days, I found them to be almost useless in reducing the pain, and if anything made it worse by making me more present in each moment, rather than in some kind of shock induced delirium.
Thank you for the explanation, but I'm failing to understand why the medical community even keeps chasing other (ineffective?) options beyond the usual suspect of Greed wanting to sell some patented crap that hardly works. If the relief is believed to be from the fact that it's a vasoconstrictor (odd, because personally I would think relief would be provided from the exact opposite), then I don't know why we don't pursue that line of study. Vasodialation (or constriction) isn't exactly new or groundbreaki
Anecdotes from a migraineur (Score:3, Interesting)
Re: Anecdotes from a migraineur (Score:2)
Re: (Score:3)
Never done acid, have you? If you don't know anything about something you're better off not making shit up.
Re: (Score:2)
You mean other than the risk of severe and sometimes irreversible memory loss.
Re: (Score:1)
Re: (Score:2)
I was referring to OP's claim that ECT is harmless (or EST as he called it). Agreed that Psilocybin has never had such an effect.
Didn't work for me (Score:2)
I had migraines for 30 years until a very good acupuncturist cured me, that was 12 years ago now. Had plenty of psilocybin experiences in that time, didn't seem to have any effect.